Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Dialysis

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

Hemodialysis II: Procedure and Complications

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CyExpDB: a web-based multi-species tissue-specific gene expression platform for functional genomics in Cyprinidae fish.

Database : the journal of biological databases and curation·2025

Same author

BgDB: a comprehensive genomic resource information system of bitter gourd for accelerated breeding programme.

Database : the journal of biological databases and curation·2025

Same author

Assessment of eVIN (Electronic Vaccine Intelligence Network) in utility and constraints of various stakeholders in Nainital District: A mixed method study.

Journal of family medicine and primary care·2025

Same author

Velocity-based Adaptive Registration and Fusion for Fractionated Stereotactic Radiosurgery Using the Small Animal Radiation Research Platform.

International journal of radiation oncology, biology, physics·2018

Same author

Peritoneal Dialysis in Patients with Abdominal Surgeries and Abdominal Complications.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018

Same author

Diagnostic Dilemma: A Case of Endogenous Peritonitis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2018

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Biocompatible peritoneal dialysis solutions: do we have one?

Kunal Chaudhary¹, Ramesh Khanna

¹Division of Nephrology and Hypertension, University of Missouri-Columbia School of Medicine, Harry S. Truman VA Medical Center, 800 Hospital Drive, Columbia, MO 65201, USA. chaudharyk@health.missouri.edu

Clinical Journal of the American Society of Nephrology : CJASN

|January 23, 2010

Summary

Newer biocompatible solutions may improve peritoneal dialysis (PD) outcomes by preserving membrane function and reducing complications. However, glucose remains the primary osmotic agent, with future solutions likely using combined agents.

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Area of Science:

Nephrology
Biomaterials Science

Background:

Peritoneal dialysis (PD) is effective for stage 5 chronic kidney disease but long-term use is limited by peritoneal membrane alterations.
Glucose in conventional PD solutions is implicated in membrane damage and systemic metabolic/cardiovascular issues.

Purpose of the Study:

To review the current status of biocompatible PD solutions.
To evaluate their efficacy in preserving peritoneal membrane function long-term compared to glucose-based solutions.

Main Methods:

Review of clinical and experimental data on biocompatible PD solutions.
Analysis of animal and human studies investigating membrane function and patient outcomes.

Main Results:

Biocompatible solutions show promise in preserving membrane function and reducing therapy failure in the short term.
Current evidence suggests newer solutions are less toxic than conventional ones, but glucose remains the primary osmotic agent.
No osmotic agent has yet safely replaced glucose for long-term PD.

Conclusions:

Biocompatible solutions may offer short-term benefits, but long-term superiority over glucose needs further investigation.
The future of PD solutions likely involves combinations of osmotic agents to enhance biocompatibility and efficacy.